Overview

Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The study will recruit 150 patients with HCV related HCC ,after HCC treatment the patients will undergo treatment with different regimens of DAAs.
Phase:
Phase 3
Details
Lead Sponsor:
National Hepatology & Tropical Medicine Research Institute
Collaborator:
Cairo University
Treatments:
Interferons
Ledipasvir
Ribavirin
Simeprevir
Sofosbuvir